Vivos (RDGL) Free Cash Flow Growth (1y) (2011 - 2025)
Vivos (RDGL) Free Cash Flow Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 28.87% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 14.12% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 0.77% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 13.29% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 142.84% |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | -11.68% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 750.00% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 0.40% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | -14.34% |
| 10 | Vivos | 24.90 Mn | 23.34 Mn | -3,105.00 | -14.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -14.58% |
| Sep 30, 2025 | 9.44% |
| Jun 30, 2025 | -70.09% |
| Mar 31, 2025 | -29.52% |
| Dec 31, 2024 | -1.68% |
| Sep 30, 2024 | -128.12% |
| Jun 30, 2024 | -13.07% |
| Mar 31, 2024 | -19.70% |
| Dec 31, 2023 | -64.43% |
| Sep 30, 2023 | 21.57% |
| Jun 30, 2023 | -83.70% |
| Mar 31, 2023 | 23.59% |
| Dec 31, 2022 | -19.62% |
| Sep 30, 2022 | -58.90% |
| Jun 30, 2022 | 50.71% |
| Mar 31, 2022 | -89.22% |
| Dec 31, 2021 | 35.59% |
| Sep 30, 2021 | 3.18% |
| Jun 30, 2021 | -45.23% |
| Mar 31, 2021 | -132.78% |